Michal Tkaczyszyn
Overview
Explore the profile of Michal Tkaczyszyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sierpinski R, Franczuk P, Tkaczyszyn M, Suchocki T, Krekora J, Opolski G, et al.
Pol Arch Intern Med
. 2021 Sep;
131(11).
PMID: 34585879
Introduction: Individual comorbidities have been shown to adversely affect prognosis in heart failure (HF). However, our knowledge of multimorbidity in HF and understanding of its prognostic implications still remain incomplete....
12.
Tkaczyszyn M, Comin-Colet J, Voors A, Van Veldhuisen D, Enjuanes C, Moliner P, et al.
Eur J Heart Fail
. 2021 May;
23(10):1677-1686.
PMID: 34050579
Aims: Abnormal endogenous erythropoietin (EPO) constitutes an important cause of anaemia in chronic diseases. We analysed the relationships between iron deficiency (ID) and the adequacy of endogenous EPO in anaemic...
13.
Kobak K, Franczuk P, Schubert J, Dziegala M, Kasztura M, Tkaczyszyn M, et al.
Cells
. 2021 Apr;
10(4).
PMID: 33917391
Cardiac fibroblasts and cardiomyocytes are the main cells involved in the pathophysiology of myocarditis (MCD). These cells are especially sensitive to changes in iron homeostasis, which is extremely important for...
14.
Tkaczyszyn M, Drozd M, Wegrzynowska-Teodorczyk K, Bojarczuk J, Majda J, Banasiak W, et al.
Cardiol J
. 2020 Nov;
28(3):391-401.
PMID: 33140393
Background: Metabolic derangements related to tissue energetics constitute an important pathophysiological feature of heart failure. We investigated whether iron deficiency and catabolic/anabolic imbalance contribute to decreased skeletal muscle performance in...
15.
Jankowska E, Tkaczyszyn M, Ponikowski P
Eur J Heart Fail
. 2020 Oct;
22(11):2047-2048.
PMID: 33034152
No abstract available.
16.
Jankowska E, Sierpinski R, Tkaczyszyn M, Drozd M, Szachniewicz J, Duda-Sikula M, et al.
Kardiol Pol
. 2020 Jul;
78(7-8):811-817.
PMID: 32687267
No abstract available.
17.
Wleklik M, Uchmanowicz I, Jankowska E, Vitale C, Lisiak M, Drozd M, et al.
Front Psychol
. 2020 Apr;
11:564.
PMID: 32273868
The concept of frailty syndrome (FS) was first described in the scientific literature three decades ago. For a very long time, we understood it as a geriatric problem, recently becoming...
18.
Jankowska E, Tkaczyszyn M, Drozd M, Ponikowski P
Eur Heart J Suppl
. 2020 Jan;
21(Suppl M):M32-M35.
PMID: 31908613
The 2016 ESC/HFA heart failure (HF) guidelines emphasize the importance of identifying and treating iron deficiency (ID) in patients with HF. Iron deficiency can occur in half or more of...
19.
Jankowska E, Vitale C, Uchmanowicz I, Tkaczyszyn M, Drozd M, Ponikowski P
Eur Heart J Suppl
. 2019 Dec;
21(Suppl L):L8-L11.
PMID: 31885505
Although heart failure (HF) is considered as a cardiogeriatric syndrome, elderly and very elderly patients are under-represented in the vast majority of clinical trials investigating novel drugs and therapies in...
20.
Tkaczyszyn M, Drozd M, Ponikowski P, Jankowska E
Kardiol Pol
. 2019 Dec;
77(12):1134-1139.
PMID: 31808423
Iron deficiency (ID) constitutes an important comorbidity affecting symptoms and outcomes in patients with heart failure (HF). Recent experimental studies and randomized clinical trials have demonstrated important novel data regarding...